Relationship between Hypercholesterolemia, Lipid-Lowering Therapy and Coronary Flow Velocity Reserve Evaluated by Stress Transesophageal Echocardiography in Patients with a Negative Coronary Angiogram

Attila Nemes, Klára Neu, T. Forster, Noémi Gruber, M. Csanády

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The coronary flow velocity reserve (CFR) depends not only on vascular, extravascular, and rheological factors, but also on metabolic factors, such as the cholesterol level. The aim of the present study was to examine the relationship between hypercholesterolemia, the application or not of 6 months lipid-lowering therapy, and the CFR evaluated by pharmacological stress transesophageal echocardiography (PSTEE) in patients without major coronary artery disease. Patients and Methods: Sixty-nine patients with a negative coronary angiogram were enrolled in the study. Thirty-two of these patients received lipid-lowering therapy, while 37 did not. The CFR was measured by means of dipyridamole PSTEE in all cases, and was calculated as the ratio of posthyperemic to basal peak diastolic flow velocities. Results: Of the 32 patients who received lipid-lowering medication, the cholesterol level was normal in 16 cases (CFR 2.47 ± 0.88), while it remained increased in 16 patients (CFR 2.18 ± 0.67) at the time of the examination. The 7 patients who did not participate in lipid-lowering therapy and who exhibited an increased cholesterol level were also examined (CFR 2.03 ± 0.88). In 30 patients with normal cholesterol level, who did not receive any lipid-lowering medication, the CFR was significantly increased compared to cases with an increased level (CFR 2.65 ± 0.79). Conclusion: It may be stated that in the patients who did not receive lipid-lowering medication and who displayed normocholesterolemia, the CFR evaluated by means of PSTEE was significantly higher than in the patients who had an increased cholesterol level.

Original languageEnglish
Pages (from-to)37-41
Number of pages5
JournalEchocardiography
Volume21
Issue number1
DOIs
Publication statusPublished - Jan 2004

Fingerprint

Stress Echocardiography
Transesophageal Echocardiography
Hypercholesterolemia
Angiography
Lipids
Cholesterol
Therapeutics
Pharmacology
Dipyridamole
Blood Vessels
Coronary Artery Disease

Keywords

  • Cholesterol level
  • Coronary flow
  • Ischemic heart disease
  • Transesophageal echocardiography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

@article{ea7d0208012d4806a4ac96396d434c9d,
title = "Relationship between Hypercholesterolemia, Lipid-Lowering Therapy and Coronary Flow Velocity Reserve Evaluated by Stress Transesophageal Echocardiography in Patients with a Negative Coronary Angiogram",
abstract = "The coronary flow velocity reserve (CFR) depends not only on vascular, extravascular, and rheological factors, but also on metabolic factors, such as the cholesterol level. The aim of the present study was to examine the relationship between hypercholesterolemia, the application or not of 6 months lipid-lowering therapy, and the CFR evaluated by pharmacological stress transesophageal echocardiography (PSTEE) in patients without major coronary artery disease. Patients and Methods: Sixty-nine patients with a negative coronary angiogram were enrolled in the study. Thirty-two of these patients received lipid-lowering therapy, while 37 did not. The CFR was measured by means of dipyridamole PSTEE in all cases, and was calculated as the ratio of posthyperemic to basal peak diastolic flow velocities. Results: Of the 32 patients who received lipid-lowering medication, the cholesterol level was normal in 16 cases (CFR 2.47 ± 0.88), while it remained increased in 16 patients (CFR 2.18 ± 0.67) at the time of the examination. The 7 patients who did not participate in lipid-lowering therapy and who exhibited an increased cholesterol level were also examined (CFR 2.03 ± 0.88). In 30 patients with normal cholesterol level, who did not receive any lipid-lowering medication, the CFR was significantly increased compared to cases with an increased level (CFR 2.65 ± 0.79). Conclusion: It may be stated that in the patients who did not receive lipid-lowering medication and who displayed normocholesterolemia, the CFR evaluated by means of PSTEE was significantly higher than in the patients who had an increased cholesterol level.",
keywords = "Cholesterol level, Coronary flow, Ischemic heart disease, Transesophageal echocardiography",
author = "Attila Nemes and Kl{\'a}ra Neu and T. Forster and No{\'e}mi Gruber and M. Csan{\'a}dy",
year = "2004",
month = "1",
doi = "10.1111/j.0742-2822.2004.03009.x",
language = "English",
volume = "21",
pages = "37--41",
journal = "Echocardiography",
issn = "0742-2822",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Relationship between Hypercholesterolemia, Lipid-Lowering Therapy and Coronary Flow Velocity Reserve Evaluated by Stress Transesophageal Echocardiography in Patients with a Negative Coronary Angiogram

AU - Nemes, Attila

AU - Neu, Klára

AU - Forster, T.

AU - Gruber, Noémi

AU - Csanády, M.

PY - 2004/1

Y1 - 2004/1

N2 - The coronary flow velocity reserve (CFR) depends not only on vascular, extravascular, and rheological factors, but also on metabolic factors, such as the cholesterol level. The aim of the present study was to examine the relationship between hypercholesterolemia, the application or not of 6 months lipid-lowering therapy, and the CFR evaluated by pharmacological stress transesophageal echocardiography (PSTEE) in patients without major coronary artery disease. Patients and Methods: Sixty-nine patients with a negative coronary angiogram were enrolled in the study. Thirty-two of these patients received lipid-lowering therapy, while 37 did not. The CFR was measured by means of dipyridamole PSTEE in all cases, and was calculated as the ratio of posthyperemic to basal peak diastolic flow velocities. Results: Of the 32 patients who received lipid-lowering medication, the cholesterol level was normal in 16 cases (CFR 2.47 ± 0.88), while it remained increased in 16 patients (CFR 2.18 ± 0.67) at the time of the examination. The 7 patients who did not participate in lipid-lowering therapy and who exhibited an increased cholesterol level were also examined (CFR 2.03 ± 0.88). In 30 patients with normal cholesterol level, who did not receive any lipid-lowering medication, the CFR was significantly increased compared to cases with an increased level (CFR 2.65 ± 0.79). Conclusion: It may be stated that in the patients who did not receive lipid-lowering medication and who displayed normocholesterolemia, the CFR evaluated by means of PSTEE was significantly higher than in the patients who had an increased cholesterol level.

AB - The coronary flow velocity reserve (CFR) depends not only on vascular, extravascular, and rheological factors, but also on metabolic factors, such as the cholesterol level. The aim of the present study was to examine the relationship between hypercholesterolemia, the application or not of 6 months lipid-lowering therapy, and the CFR evaluated by pharmacological stress transesophageal echocardiography (PSTEE) in patients without major coronary artery disease. Patients and Methods: Sixty-nine patients with a negative coronary angiogram were enrolled in the study. Thirty-two of these patients received lipid-lowering therapy, while 37 did not. The CFR was measured by means of dipyridamole PSTEE in all cases, and was calculated as the ratio of posthyperemic to basal peak diastolic flow velocities. Results: Of the 32 patients who received lipid-lowering medication, the cholesterol level was normal in 16 cases (CFR 2.47 ± 0.88), while it remained increased in 16 patients (CFR 2.18 ± 0.67) at the time of the examination. The 7 patients who did not participate in lipid-lowering therapy and who exhibited an increased cholesterol level were also examined (CFR 2.03 ± 0.88). In 30 patients with normal cholesterol level, who did not receive any lipid-lowering medication, the CFR was significantly increased compared to cases with an increased level (CFR 2.65 ± 0.79). Conclusion: It may be stated that in the patients who did not receive lipid-lowering medication and who displayed normocholesterolemia, the CFR evaluated by means of PSTEE was significantly higher than in the patients who had an increased cholesterol level.

KW - Cholesterol level

KW - Coronary flow

KW - Ischemic heart disease

KW - Transesophageal echocardiography

UR - http://www.scopus.com/inward/record.url?scp=0842291612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842291612&partnerID=8YFLogxK

U2 - 10.1111/j.0742-2822.2004.03009.x

DO - 10.1111/j.0742-2822.2004.03009.x

M3 - Article

C2 - 14717719

AN - SCOPUS:0842291612

VL - 21

SP - 37

EP - 41

JO - Echocardiography

JF - Echocardiography

SN - 0742-2822

IS - 1

ER -